Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study

There was an error in figure 4 of a paper by Simms-Williams and colleagues published in BMJ. The correct title for table 3 should be “Mean (SD) duration of SGLT-2 inhibitor use, years” instead of GLP-1 receptor agonist use. The correction was made to accurately reflect the data presented in the paper.

Source link